Evidence map›Paper›PMID 42187443›Full record

ReviewBiosensors2026

DNA Origami and Their Application in Biosensors.

Iqra Nosheen Salim, Rebecca Reay, Christine Denby, Chris Halloran, Tien Anh Ngo, Jon Ashley

Abstract readReview
In one paragraph

Review in Biosensors, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Iqra Nosheen SalimSchool of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, 3 Byrom way, Liverpool L3 3AF, UK.ORCID 0009-0000-6663-2471
Rebecca ReaySchool of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, 3 Byrom way, Liverpool L3 3AF, UK.
Christine DenbySchool of Nursing, Public and Allied Health, Liverpool John Moores University, 79 Tithebarn Street, Liverpool L2 2ER, UK.
Chris HalloranDepartment of Molecular & Clinical Cancer Medicine, Institute of Systems, Molecular & Integrative Biology, University of Liverpool, Liverpool L7 8XT, UK.ORCID 0000-0002-5471-4178
Tien Anh NgoInstitute for Regenerative Medicine, Hanoi 100000, Vietnam.ORCID 0000-0002-4681-4080
Jon AshleySchool of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, 3 Byrom way, Liverpool L3 3AF, UK.ORCID 0000-0002-7062-1019

Funding

CAMS Fellowship 600310/22/06Engineering and Physical Sciences Research Council EP/Y024168/1 and IBIC-ReB-002
6 · The paper itself

Abstract

Biosensors have evolved significantly since their invention in the mid-twentieth century. From a simple electrochemical device to the current inclusion of AI, these sophisticated tools are capable of label-free, real-time multiplex detection. To make these sensing systems even more powerful, the incorporation of DNA origami has allowed this technology to become extremely precise, recognisable, and programmable to a range of molecules. This paper systematically summarises the incorporation of DNA origami with biosensors such as fluorescence, surface-enhanced Raman spectroscopy (SERS), surface plasmon resonance (SPR), and electrochemical sensors as well as approaches that are used to design DNA origami nanostructures. These tools allow a range of targets to be detected, ranging from small molecules to larger biological species. Collectively, these studies demonstrate that DNA origami-based biosensors provide high sensitivity; precise spatial control; and rapid, modular detection capabilities. Furthermore, their versatility enables applications across a diverse range of sectors. However, key challenges including limited reproducibility, structural instability, photobleaching, and non-specific binding continue to hinder their widespread adoption. This review proposes future directions aimed at overcoming key limitations, including enhancing biocompatibility and structural stability, to support the development of more advanced and clinical point-of-care-applicable biosensors.

Indexed as

Biosensing TechniquesDNA NanostructuresAnimalsElectrochemical TechniquesFluorescent DyesHumansSurface Plasmon ResonanceWearable Electronic DevicesFluorescent Dyesbiosensorsdesign toolsdiagnosticsDNA nanostructuresDNA origami

Identifiers

PMID42187443
PMCPMC13204131

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.